An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection

European Journal of Immunology

Volumn 32, Issue 10, 2002, Pages 2923-2933

  Alexander, James ^a   Brombacher, Frank ^b   McGachy, H Adrienne ^a   McKenzie, Andrew N J ^c   Walker, William ^a   Carter, K Christine ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

IFN ; IL 12R 2; IL 13; IL 4; Leishmania mexicana

Indexed keywords

ANTIBODY; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; GROWTH; HEALING; INFECTION RESISTANCE; LEISHMANIA MEXICANA; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; TH1 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; CYTOKINES; INTERLEUKIN-13; INTERLEUKIN-4; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, SCID; RECEPTORS, INTERLEUKIN-4;

EID: 0036773192     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2002010)32:10<2923::AID-IMMU2923>3.0.CO;2-E     Document Type: Article

References (50)

1. Alexander, J., Satoskar, A. R. and Russell, D. G., Leishmania species: models of intracellular parasitism. J. Cell Science 1999. 112: 2993-3002.
2. Scott, P. and Farrell, J. P., Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chem. Immunol. 1998. 70: 60-80.
3. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997. 6: 541-549.
4. Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J. A. and Launois, P., The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor β2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 1998. 161: 6156-6163.
5. Guler, M. L., Gorham, J. D., Hsieh, C. S., Mackey, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M., Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996. 271: 984.
6. Reiner, S. L., Zheng, S., Wang, Z. -E., Sowring, L. and Locksley, R. M., Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 1994. 179: 447-456.
7. Jones, D. E., Buxbaum, L. U. and Scott, P., IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 2000. 165: 364-372.
8. Noben-Trauth, N., Kopf, P. and Muller, I., Susceptibility to Leishmania major in interleukin-4-deficient mice. Science 1996. 271: 987-990.
9. Satoskar, A., Bluethmann, H. and Alexander, J., Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 1995. 6: 4894.
10. Satoskar, A., Brombacher, F., Dai, W. J., McInnes, I., Liew, F. Y., Alexander, J. and Walker, W. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol. 1997. 159: 5005-5013.
11. Kopf, M., Brombacher, F., Kohler, G., Kienzie, G., Widmann, K. H., Lefrang, K., Humborg, C., Ledermann, B. and Solbach, W., IL-4-deficient mice resist infection with Leishmania major. J. Exp. Med., 1996. 184: 1127-1136.
12. Noben-Trauth, N., Paul, W. E. and Sacks, D. L., IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 1999. 162: 6132-6140.
13. Mohrs, M., Lederman, B., Koehler, G., Dorfmueller, A., Gessner, A. and Brombacher, F., Differences between IL-4- and IL-4α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signalling. J. Immunol. 1999. 162: 7302-7308.
14. Mohrs, M., Holscher, C. and Brombacher, F., Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 2000. 68: 1773-1780.
15. Alexander, J., Carter, K. C., Al-Fasi, N., Satoskar, A. and Brombacher, F. Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis. Eur. J. Immunol. 2000. 30: 2935-2943.
16. Brombacher, F., The role of interleukin-13 in infectious diseases and allergy. BioEssay 2000. 22: 646-656.
17. Matthews, D. J., Emson, C. L., McKenzie, G. J., John, H. E., Blackwell, J. M. and McKenzie, A. N. J., IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 2000. 164: 1458-1462.
18. Stamm, L. M., Raisanen-Sokolowski, A., Okano, M., Russell, M. R., David, J. R. and Satoskar, A. R., Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol. 1999. 161: 2524-2529.
19. Sosa, M. R., Rosas, L. E., McKenzie, A. N. J. and Satoskar, A. R., IL-13 gene-deficient mice are susceptible to cutaneous Leishmania mexicana infection. Eur. J. Immunol. 2001. 31: 3255-3260.
20. Roberts, M., Alexander, J. and Blackwell, J. M., Influence of Lsh, H-2 and on H-11-linked gene on visceralisation and metastasis associated with Leishmania mexicana infection in mice. Infect. Immun. 1989. 57: 875-881.
21. Weiss, G., Bogdan, C. and Hentze, M. W., Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol., 1997. 158: 420-425.
22. Juttner, S., Bernhagen, J., Metz, C. N., Rollinghoff, M., Bucala, R, and Gessner, A., Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-α. J. Immunol. 1998. 161: 2383-2390.
23. Skeen, M. J., Miller, M. A., Shinnick T. M. and Ziegler, H. K., Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 1996. 156: 1196-1206.
24. Paludan, S. R., Lovmand, J., Ellermann-Eriksen, S. and Mogensen, S. C., Effect of IL-4 and IL-13 on IFN-gamma-induced production of nitric oxide in mouse macrophages infected with herpes simplex virus type 2. FEBS Lett. 1997. 414: 61-64.
25. Doyle, A. G., Herbein, G., Montaner, L. J., Minty, A. J., Caput, D., Ferrara, P. and Gordon, S., Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur. J. Immunol. 1994. 24: 1441-1445.
26. Di Santo, E., Meazza, C., Sironi, M., Fruscella, P., Mantovani, A., Sipe, J. D. and Ghezzi, P., IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J. Immunol. 1997. 159: 379-382.
27. Kambayashi, T., Jacob, C. O. and Strassmann, G., IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 1996. 171: 153-158.
28. de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Benett, B., Culpepper, J., Dang, W., Zurawski, G. and de Vries, J. E. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 1993. 151: 6370-6381.
29. Muchamuel, T., Menon, S., Pisacane, P., Howard, M. C. and Cockayne, D. A., IL-13 protects mice for lipopolysaccharide-induced lethal endotoxemia. J. Immunol. 1997. 158: 2898-2903.
30. Vouldoulkis, I., Becherel, P. A., Rivers-Moreno, V., Arock, M., da Saliva, O., Debre, P., Mazier, D. and Mossalayi, M. D. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 1997. 27: 860-865.
31. Vieth, M., Will, A., Schroppel, K., Rollinghoff, M. and Gessner, A., Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 1994. 40: 403-409.
32. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, Z., Kubin, M. and Trinchieri, G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993. 178: 1041-1048.
33. Kane, M. M. and Mosser, D. M., The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 2001. 166: 1141-1147.
34. Kima, P. E., Constant, S. L., Hannum, L., Colmenares, M., Lee, K. S., Haberman, A. M., Schlomchik, M. J. and McMahon-Pratt, D., Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 2000. 191: 1063-1068.
35. Rey, A., Quartulli, F., Escoubet, L., Sozzani, P., Caput, D., Ferrara, P. and Pipy, B., IL-13 induces serine phosphorylation of cPLA2 in mouse peritoneal macrophages leading to arachidonic acid and PGE2 production and blocks the zymosan-induced serine phosphorylation of cPLA2 and eicosanoid production. Biochim. Biophys. Acta 1999. 1440: 183-193.
36. Wu, C.-Y., Wang, K., McDyer, J. F. and Seder, R. A., Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 1998. 161: 2723-2730.
37. Milano, S., Arcoleo, F. Dieli, M., D'Agostino, R., De Nucci, G., D'Agostino, P. and Cillari, E., Ex vivo evidence for PGE2 and LTB4 involvement in cutaneous leishmaniasis: relation with infection status and cytokine production. Parasitology 1996. 112: 13-19.
38. Farrell, J. P. and Kirkpatrick C. E., Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol. 1987. 138: 902-907.
39. Grunig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M. and Corry, D. B., Requirements for IL-13 independently of IL-4 in experimental asthma. Science 1998. 282: 2261-2263.
40. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, K. C. and Donaldson, D. D., Interleukin-13: central mediator of allergic asthma. Science 1998. 282: 2258-2261.
41. Mountford, A. P., Hogg, K. G., Coulson, P. S. and Brombacher, F., Signaling via interleukin-4 receptor α chain is required for successful vaccination against schistomiasis in BALB/c mice. Infect. Immun. 2001. 69: 228-236.
42. Barner, M., Mohrs, M., Brombacher, F. and Kopf, M., Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 1998. 8: 669-672.
43. Guo, L., Hu-Li, J., Pannetier, C., Watson, C., McKenzie, G. J., McKenzie, A. N. and Paul, W. E., Disrupting IL13 impairs production of IL-4 specified by the linked allele. Nat. Immunol. 2001. 2: 461-466.
44. Faquim-Maura, E. L., Coffman, R. L., Abrahamsohn, I. A. and Macedo, M. S., Cutting edge: Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol. 1999. 163: 3572-3576.
45. Snapper, C. M., Finkelman, F. D. and Paul, W. E., Differential regulation of IgG1 and IgE synthesis by interleulkin 4. J. Exp. Med. 1988. 167: 183-196.
46. Heinzel, F. P., Sadick, M. D. Holaday, B. J., Coffman, R. L. and Locksley, R. M., Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper t cell subsets. J. Exp. Med. 1989. 169: 59-72.
47. Jones, D., Merle, E. M., Showe, L., Williams, D., Trinchieri, G. and Scott, P., Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun. 1998. 66: 3818-3824.
48. Bourreau, E., Prevot, G., Pradinaud, R. and Launois, P., Interleukin (IL)-13 is the predominant Th2 cytokine in localised cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12. Infect. Dis. 2001. 183: 953-959.
49. McKenzie, G. J., Fallon, P. G., Emson, C. L., Grencis, R. K. and McKenzie, A. M. J., Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2 mediated responses. J. Exp. Med. 1999. 189: 1565.
50. McKenzie, G. J., Bancroft, A., Grencis, R. K. and McKenzie, A. N., A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 1998. 8: 339-342.